Two medical device makers are preparing initial public offerings for the coming weeks, breaking up a spree of biotech IPOs that have dominated the market.
ReWalk Robotics, formerly Argo Medical Technologies, is preparing an initial public offering worth up to $57.5 million, according to regulatory filings.
FDA regulators announced this evening that they approved for the U.S. market the 1st robotic exo-suit for helping patients with lower-body paralysis walk upright.
Called ReWalk , the motorized system is comprised of metal leg braces that strap around the legs and back, supplying movement to joints in the hips, knees and ankles. The system includes a watch-based remote that controls the suit’s movements and patients rely on crutches to provide stability.